Interestingly, FHOD1 immunoreactivity was mild or absent in the well-differentiated areas of invasive cancer, indicating that the tumour bulk that consists of cellular areas with epithelial differentiation expresses little FHOD1. This evidence concerns the gene FHOD1 and cancer.